Microviable Therapeutics is celebrating World Microbiome Day 2023! We share how important microbes are for the health of humans, animals, plants, oceans and the entire planet. Through increased awareness and education we can create a [...]
Microviable Therapeutics will be presenting at the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. Noelia Martínez, R&D Director, Pilar Manrique, Research Scientist and Marta F. Gosende, Research [...]
Microviable Therapeutics is thrilled to announce that will be attending the Microbiome & Probiotic R&D & Business Collaboration Forum taking place on May 23rd-24th at Rotterdam. The event will bring together academic, industry, and investment [...]
Microviable welcomes to the team our new internship student Alejandro Ojeda Suárez, Biologist with a Master's in Physiology and Clinical and Biomedical Laboratory Technician.
We are looking for a full-time, highly motivated lab technician to work on our team on-site (Oviedo, Asturias, Spain). The ideal candidate will have experience in microbiology, biochemistry, immunology, microbiota and probiotics, and will join [...]
Microviable Therapeutics was selected to present at Anglonordic Life Science Conference 2023, taking place on April 20th in London. Exclusively selected attendees will represent the key drivers of the European life sciences growth sector. Microviable's [...]
Our new research article: “GutAlive® enables DNA-based microbiome analysis without disrupting the original composition and diversity” A precise faecal microbiome analysis requires normalized methods for microbiome sampling, transport and manipulation in order to obtain [...]
Microviable Therapeutics announced the appointment of Dr. Luis Gosálbez as a member of its Business Advisory Board. Gosálbez brings 10 years of experience in business strategy and corporate development for life sciences companies specialized in [...]
Microviable Therapeutics will be presenting at XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. Claudio Hidalgo, CEO at Microviable, Noelia Martínez, R&D Director, and Ignacio [...]
Microviable Therapeutics will be attending the XIV Workshop of SEMiPYP (Spanish Society of Microbiota, Probiotics and Prebiotics) taking place on March 8th-10th at Pamplona. The event will make special mention of the new advances in [...]